| • Controlled drugs
• Locum pharmacy
• Medicines distribution
• Retention fees (2)
• Premises fees
• Supervision
• The profession
• Postgraduate education
Letters to the Editor
|
Retention fees
Staged payments
From Mr P. R. Breame, MRPharmS
It appears that there is a will, after all, to introduce staged payments
for the retention fee, albeit too late this year for the many “unfortunates” like
myself who do not have the luxury of reimbursement of fees from their
employer.
Perhaps I should, unreservedly, apologise for my previous criticisms
over the belated (by many years) move towards this option?
But wait. Did I see a typographical error in the announcement? Maybe
I was looking through a disbelieving haze, but did the announcement
say that the first staged payment would be on 1 December 2008?
Surely,
that
should read 1 January 2009? That is when the fee is due. Or are we
being conned yet again? Paul Breame
Little Clacton, Essex
| |
ANDREW GUSH, Treasurer of the Royal Pharmaceutical
Society, responds:
The Society’s Council understands it has
a clear mandate to introduce staged payments, while acknowledging
that
there is still some way to go before the Society can offer this
service to members.
We are working to ensure that the Society is
not the limiting factor in the introduction of staged payments. The
responses to the fees consultation made clear an element of disquiet
with the current fee year being aligned to the calendar
year, so we are considering a staged payment cycle, with payments
falling due on or around 1 December, 1 March, 1 June and 1 September,
and 1 January for lump sum payments.
The Society will consult
with members and registrants before making the changes necessary
to
bring about staged payments and, while we are always open to
comments, if there are concerns about the timing of the payments
or perhaps
some helpful suggestions, then these could be made as part
of that consultation. |
Part-time comparisons
From Mr C. W. Lewis, MRPharmS
In answer to the question of why there are no concessions for pharmacists
who work part time, Andrew Gush, the Royal Pharmaceutical Society’s
Treasurer, says this is because the cost involved in registering members
is the same regardless of the hours worked and a concessionary fee could
only be achieved at the cost of those who perhaps had no choice but to
work full time.
This does not account for those who have no choice but to work part time,
nor does it explain how a part-time fee was accommodated without any
apparent problem up until just a few years ago, nor does it accord with
the general principle in the UK that tax and benefit levels are based
on means.
In my fees consultation response I pointed out that the General Medical
Council lists the 2008 annual retention fee for doctors at £290
and offers a 50 per cent lower-income discount to doctors who expect
to earn less than £19,700 in 2008.
If income exceeds that amount
the discount can be revoked and the balance of £145 paid at the
end of the year.
Why can this principle not, albeit with perhaps different figures, be
readopted for part-time pharmacists? Chris Lewis
Bristol |